Generalised urticaria induced by topical cyclopentolate
نویسندگان
چکیده
منابع مشابه
Urticaria induced by antihistamines.
H1-antihistamines are commonly used drugs, and probably the most frequently used for allergic diseases. They are pharmacologic inverse agonists of histamine at H1 receptor sites and try to shift the equilibrium of this receptor toward the inactive state, preventing H1 response. A wide variety of adverse effects have been attributed to antihistamines, and they can exceptionally induce skin react...
متن کاملÜrtikeri Neonatal Urticaria Due To Topical Mupirocin
Özet Ürtiker çocukluk çaðýnda sýk görülen deri hastalýklarýndan biridir, ancak 6 aydan küçük yaþta nadirdir. Bu yaþ grubuna özgü ürtikerin özelliklerini, etyolojisini ve tedavisini tanýmlayan sadece birkaç çalýþma vardýr. Ürtiker 6 aydan küçüklerde nadir olduðundan ve bu yaþ grubunda sadece bir kaç tedavinin etkinliði ve güvenilirliði denenmiþ olduðundan, literatürde tedavisi ile ilgili çok az ...
متن کاملAcute Urticaria Induced by Oral Methylprednisolone
Although corticosteroids have immunosuppressive, anti-inflammatory, and anti-allergic effects, allergic reactions are rare. We report a case involving a 52-year-old-female with acute urticaria caused by oral methylprednisolone. The patient had experienced aspirin-exacerbated respiratory disease (AERD) for 13 years with frequent asthma exacerbations. Symptoms of asthma exacerbations improved wit...
متن کاملFexofenadine-Induced Urticaria
Fexofenadine (Allegra® 180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine-induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Eye
سال: 1996
ISSN: 0950-222X,1476-5454
DOI: 10.1038/eye.1996.176